Two Chinese pharma firms seek Hong Kong listings, incl. Salubris
Shenzhen Salubris Pharmaceuticals has applied for a Hong Kong listing, per an exchange filing. The sector is cited as the next wave of offerings in the city; no listing timeline details were provided.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.